Evidence map›Paper›PMID 39838885›Full record

ArticleJournal of materials chemistry. B2025

Synergistic antibacterial drug elution from UHMWPE for load-bearing implants.

Nicoletta Inverardi, Maria F Serafim, Anthony Marzouca, Keita Fujino, Matheus Ferreira, Mehmet D Asik, Amita Sekar, Orhun K Muratoglu, Ebru Oral

Abstract read
In one paragraph

Article in Journal of materials chemistry. B, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 2 papers.

0numbers the graph read from it
0cells of the map it votes in
2citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

2 citing papers in PubMed.

  1. Review
  2. Toughness measures in solid-state composites of ultra-high molecular weight polyethylene.Journal of the mechanical behavior of biomedical materials · 2025
    Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

9 authors.

Nicoletta InverardiHarris Orthopaedic Laboratory, Massachusetts General Hospital, Boston, Massachusetts 02114, USA. eoral@mgh.harvard.edu.ORCID http://orcid.org/0000-0003-3550-9299
Maria F SerafimHarris Orthopaedic Laboratory, Massachusetts General Hospital, Boston, Massachusetts 02114, USA. eoral@mgh.harvard.edu.
Anthony MarzoucaHarris Orthopaedic Laboratory, Massachusetts General Hospital, Boston, Massachusetts 02114, USA. eoral@mgh.harvard.edu.
Keita FujinoHarris Orthopaedic Laboratory, Massachusetts General Hospital, Boston, Massachusetts 02114, USA. eoral@mgh.harvard.edu.ORCID http://orcid.org/0009-0003-2487-1302
Matheus FerreiraHarris Orthopaedic Laboratory, Massachusetts General Hospital, Boston, Massachusetts 02114, USA. eoral@mgh.harvard.edu.
Mehmet D AsikHarris Orthopaedic Laboratory, Massachusetts General Hospital, Boston, Massachusetts 02114, USA. eoral@mgh.harvard.edu.
Amita SekarHarris Orthopaedic Laboratory, Massachusetts General Hospital, Boston, Massachusetts 02114, USA. eoral@mgh.harvard.edu.ORCID http://orcid.org/0000-0002-2057-1332
Orhun K MuratogluHarris Orthopaedic Laboratory, Massachusetts General Hospital, Boston, Massachusetts 02114, USA. eoral@mgh.harvard.edu.
Ebru OralHarris Orthopaedic Laboratory, Massachusetts General Hospital, Boston, Massachusetts 02114, USA. eoral@mgh.harvard.edu.ORCID http://orcid.org/0000-0001-5761-719X

Funding

Drug-eluting joint implants with synergistic antimicrobial release and risk stratified models of preclinical efficacy testingR01AR077023 · NIAMS · MASSACHUSETTS GENERAL HOSPITAL · PI ORAL, EBRU · 2020 to 2024
$1.8M
NIAMS NIH HHS R01 AR077023
6 · The paper itself

Abstract

Total joint replacement is a successful procedure for restoring the patient's musculoskeletal mobility and quality of life, but it carries the risk of severe peri-prosthetic joint infections (PJI) and is accompanied by post-operative pain. Cocktails of multiple drugs are often used for prevention/treatment of PJI and for addressing pain. Local drug delivery systems are promising for improving the outcome of the treatment and decreasing the side effects of systemic drugs. To this end, the ultra-high molecular weight polyethylene (UHMWPE) bearing surface of the joint implant is here proposed as a platform for simultaneous release of multiple therapeutics. The combined use of non-antibiotic drugs and antibiotics, and their incorporation into UHMWPE allows to obtain novel antibacterial implant materials. The combined elution of analgesics and antibiotics from UHMWPE is found to be synergistically effective in eradicating

Indexed as

Anti-Bacterial AgentsPolyethylenesStaphylococcus aureusDrug LiberationMicrobial Sensitivity TestsParticle SizeSurface PropertiesAnti-Bacterial AgentsPolyethylenesultra-high molecular weight polyethylene

Identifiers

PMID39838885
PMCPMC11874067

What OpenQuestion holds

Textmetadata
LicenceTDM
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.